HOME >  研究?論文業績 > 2024年

2024年

Noise Pareidolia Test in Parkinson’s Disease and Atypical Parkinsonian Syndromes: A Retrospective Study.
Matsumoto T, Koh J, Sakata M, Nakayama Y, Yorozu S, Taruya J, Takahashi M, Miyamoto K, Ito H. Cureus. 2024 Mar 3; 16(3): e55436.
Intravenous methylprednisolone therapy for ocular myasthenia gravis: A retrospective study.
Yorozu S, Koh J, Miyamoto K, Sakata M, Nakayama Y, Takahashi M, Mori M, Taruya J, Matsumoto T, Minamino M, Ogami S, Niwa M, Hiwatani Y, Kajimoto Y, Ishiguchi H, Ito Neurology and Clinical Neuroscience. https://doi.org/10.1111/ncn3.12810.
Three-year follow-up of rheumatoid meningitis with matrix metalloprotease-9 levels in the serum and cerebrospinal fluid as indicators of disease activity: A case report.
Murakami K, Miyamoto K, Koh J, Kajimoto Y, Ito H. J Neuroimmunol. 2024 May 15;390:578331.
Prevalence, Impact, and Screening Methods of Sarcopenia in Japanese Patients With Parkinson’s Disease: A Prospective Cross-Sectional Study.
Murakami K, Koh J, Ogami S, Aoki Y, Hori K, Emori S, Matsumoto T, Taruya J, Yorozu S, Sakata M, Nakayama Y, Miyamoto K, Ito H. Cureus. 2024 Jul 24; 16(7): e65316.
Clinical practice guidelines for multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease 2023 in Japan.
Niino M, Isobe N, Araki M, Ohashi T, Okamoto T, Ogino M, Okuno T, Ochi H, Kawachi I, Shimizu Y, Takahashi K, Takeuchi H, Tahara M, Chihara N, Nakashima I, Fukaura H, Misu T, Miyazaki Y, Miyamoto K, Mori M, Kinoshita M, Takai Y, Fujii C, Watanabe M, Fujihara K. Mult Scler Relat Disord. 2024 Oct; 90: 105829
Japanese Mucuna pruriens (Hasshou beans) showed fast and long effects in Parkinson’s disease.
Sakata M, Miyamoto K, Koh J, Nagashima Y, Kondo T, Ito H. Intern Med. 2024 Oct 15; 63(20): 2773-2779.
 

PAGE TOP